AKT1 and cancer: The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway deregulation is a common event in human cancer and associated with the tumor cell proliferation, growth and apoptosis [12, 13].